FDA Revitalization Bill Clears House, Heads For Conference
This article was originally published in The Tan Sheet
Executive Summary
The House followed the Senate July 11 in passing "FDA Revitalization" legislation calling for greater access to more medicines and strengthening the agency's post-marketing authority